NEW YORK, Dec. 23, 2016 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of TerraVia Holdings, Inc. securities (NASDAQ:TVIA) from August 8, 2016 through November 7, 2016, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for TerraVia investors under the federal securities laws.
To join the TerraVia class action, go to http://www.rosenlegal.com/cases-989.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period Defendants made false and/or misleading statements and/or failed to disclose that: (1) TerraVia’s products caused gastrointestinal distress, such as nausea and vomiting; and (2) as a result, Defendants’ statements about TerraVia’s business, operations, and prospects were false and misleading and/or lacked a reasonable basis at all relevant times. On November 7, 2016, Bloomberg reported that TerraVia sent a letter to a distributor in July warning that TerraVia had received reports showing that algal protein can cause gastrointestinal distress. On this news, shares of TerraVia fell $0.15 per share or over 8% to close at $1.70 per share on November 7, 2016, damaging investors.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than January 17, 2017. If you wish to join the litigation, go to http://www.rosenlegal.com/cases-989.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim or Kevin Chan of Rosen Law Firm toll free at 866-767-3653 or via email at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Fortescue Expands Copper Portfolio With Full Takeover of Alta Copper
Air Force One Delivery Delayed to 2028 as Boeing Faces Rising Costs
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market
Woolworths Faces Fresh Class Action Over Alleged Underpayments, Shares Slide
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand
Strategy Retains Nasdaq 100 Spot Amid Growing Scrutiny of Bitcoin Treasury Model
Korea Zinc to Build $7.4 Billion Critical Minerals Refinery in Tennessee With U.S. Government Backing
FAA Unveils Flight Plan 2026 to Strengthen Aviation Safety and Workforce Development
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns
United Airlines Tokyo-Bound Flight Returns to Dulles After Engine Failure
Coca-Cola’s Proposed Sale of Costa Coffee Faces Uncertainty Amid Price Dispute
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 



